Likewise, in childhood ALL, the generation of a risk score based on the combination of MRD at day 33, the presence of IKZF1 intragenic deletion and P2RY8-CRLF2, which proved more discriminative of outcome that MRD evaluation alone, has been recently reported (131). The gene discussed is IKZF1; the disease is acute lymphoblastic leukemia.